Adrenergic alpha-2 Receptor Agonists
"Adrenergic alpha-2 Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.
| Descriptor ID |
D058647
|
| MeSH Number(s) |
D27.505.519.625.050.100.100.200 D27.505.696.577.050.100.100.200
|
| Concept/Terms |
Adrenergic alpha-2 Receptor Agonists- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha 2 Receptor Agonists
- Adrenergic alpha2-Agonists
- Adrenergic alpha2 Agonists
- alpha2-Agonists, Adrenergic
- Adrenergic alpha-2 Agonists
- Adrenergic alpha 2 Agonists
- Agonists, Adrenergic alpha-2
- alpha-2 Agonists, Adrenergic
- Adrenergic alpha-2 Receptor Agonist
- Adrenergic alpha 2 Receptor Agonist
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic alpha-2 Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic alpha-2 Receptor Agonists".
This graph shows the total number of publications written about "Adrenergic alpha-2 Receptor Agonists" by people in this website by year, and whether "Adrenergic alpha-2 Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 0 | 4 |
| 2018 | 4 | 2 | 6 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic alpha-2 Receptor Agonists" by people in Profiles.
-
Pediatric COVID-19 Delirium: Case Report of 2 Adolescents. WMJ. 2021 Jul; 120(2):131-136.
-
Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU. Br J Anaesth. 2021 01; 126(1):e33-e35.
-
Academy News. Neonatal Netw. 2020 08 01; 39(5):306-311.
-
Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19. Psychosomatics. 2020 Nov - Dec; 61(6):585-596.
-
COVID-19-Associated Hyperactive Intensive Care Unit Delirium With Proposed Pathophysiology and Treatment: A Case Report. Psychosomatics. 2020 Sep - Oct; 61(5):544-550.
-
Novel Use of Brimonidine 0.33% Gel for Hemostasis in Nail Surgery. Dermatol Surg. 2019 07; 45(7):993-996.
-
The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial. PLoS One. 2018; 13(11):e0207427.
-
FDA approves nonopioid medication for managing opioid withdrawal. Am J Health Syst Pharm. 2018 Jul 01; 75(13):927.
-
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial. BMJ Open. 2018 04 20; 8(4):e020316.
-
Stimulation of alpha2-adrenergic receptors impairs influenza virus infection. Sci Rep. 2018 03 15; 8(1):4631.